Eagle Pharmaceuticals

Traded on the St. Petersburg Stock Exchange
Eagle Pharmaceuticals is a pharmaceutical company realizing the untapped potential of life-saving medicines.
Eagle Pharmaceuticals stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Eagle Pharmaceuticals balance sheet

Report period2018 2019 2020 2021 2022Q2 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Eagle Pharmaceuticals cash flows

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Eagle Pharmaceuticals multipliers

Report period2018 2019 2020 2021 2022Q2 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Eagle Pharmaceuticals profitability

Report period2018 2019 2020 2021 2022Q2 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Eagle Pharmaceuticals assets
Eagle Pharmaceuticals cash flows

Eagle Pharmaceuticals shares

TickerNameTypeNominal valueISINPrice
EGRX:USEagle Pharmaceuticals, Inc.Common share-US2697961082$4.61
Eagle Pharmaceuticals news
11.05.2022
Eagle Pharmaceuticals' GAAP net income for 3 months of 2022 was $44.058 million, compared to a loss of $0.421 million in the previous year. Revenue increased 2.8 times to $115.874 million from $41.249 million a year earlier.
Source: {source} pictogram investor.eagleus.com
Pictogram next
28.03.2022
Eagle Pharmaceuticals acquires pharmaceutical company Acacia Pharma for €94.7 million. Acacia develops drugs designed to help patients recover from surgery or chemotherapy. The deal is expected to close at the end of Q2 2022.
Source: {source} pictogram investor.eagleus.com
Pictogram next
07.03.2022
Eagle Pharmaceuticals' GAAP loss for 2021 was $8.627 million, compared to a profit of $11.989 million in the previous year. Revenues fell 8.7% to $171.546 million from $187.802 million a year earlier.
Source: {source} pictogram investor.eagleus.com
Pictogram next
09.11.2021
Eagle Pharmaceuticals' GAAP loss for 9M 2021 was $2.431 million, compared to a profit of $3.932 million in the previous year. Revenue declined 6.3% to $129.226 million from $137.886 million a year earlier.
Source: {source} pictogram investor.eagleus.com
Pictogram next
All Eagle Pharmaceuticals news
General information
Company nameEagle Pharmaceuticals
Tags#pharmacy
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
Mailing address50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Websitewww.eagleus.com
Information disclosurewww.sec.gov